Elimination of Hepatitis C in Liver Transplant Recipients

Background and Aims: Recurrent hepatitis C (HCV) disease in liver transplant (LT) recipients is associated with significant morbidity and mortality. With the availability of noninterferon-based therapy, eliminating HCV may be achievable in LT recipients. Methods: We studied all consecutive recipient...

Descripción completa

Detalles Bibliográficos
Autores principales: Saab, Sammy, Challita, Youssef, Chen, Phillip H., Jimenez, Melissa A., Lee, Alex D., Saab, Elena G., Ahn, Timothy, Choi, Gina, Durazo, Francisco A., El-Kabany, Mohamed M., Han, Steven-Huy B., Grotts, Jonathan, Agopian, Vatche G., Busuttil, Ronald W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160303/
https://www.ncbi.nlm.nih.gov/pubmed/30271735
http://dx.doi.org/10.14218/JCTH.2017.00079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160303/
https://www.ncbi.nlm.nih.gov/pubmed/30271735
http://dx.doi.org/10.14218/JCTH.2017.00079

Ejemplares similares